Open AccessConversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study
Author(s) -
WeiFeng Qu,
ZhenBin Ding,
Xu-Dong Qu,
Zheng Tang,
Guiqi Zhu,
XiuTao Fu,
Zi-Han Zhang,
Xin Zhang,
Ao Huang,
Min Tang,
MengXin Tian,
XiFei Jiang,
Run Huang,
Chenyang Tao,
Yuan Fang,
Jun Gao,
Xiao-Ling Wu,
Jian Zhou,
Jia Fan,
WeiRen Liu,
YingHong Shi
Publication year - 2022
Publication title -
bjs open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.974
H-Index - 9
ISSN - 2474-9842
DOI - 10.1093/bjsopen/zrac114
Subject(s) - medicine , hepatocellular carcinoma , lenvatinib , cohort , adverse effect , regimen , gastroenterology , surgery , oncology , sorafenib
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom